Gene · 369
NIH grants1,471
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 1,471
Download this page as JSON| Grant | Title | ARAF papers | Newest fiscal year |
|---|---|---|---|
| R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 1 | 2025 |
| R01HL127349 | Genomic Analysis of Tissue and Cellular Heterogeneity in IPF | 1 | 2025 |
| R01HL157387 | Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit | 1 | 2025 |
| R01LM012011 | Interpretable deep learning models for translational medicine Renewal | 1 | 2025 |
| R25CA020449 | Summer research experiences for medical students supervised by faculty mentors | 1 | 2025 |
| R35CA197570 | Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation | 1 | 2025 |
| R35CA197589 | Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities | 1 | 2025 |
| R35CA210057 | Integrating targeted therapy and immunotherapy to break through cancer | 1 | 2025 |
| R35CA253027 | Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies | 1 | 2025 |
| R35GM118145 | Nanoscale Approaches to Understanding Membrane Protein Function | 1 | 2025 |
| R35GM122480 | Proteomics and model organism humanization to decode human genetics | 1 | 2025 |
| R35GM122481 | Development and Testing of New Computational Methods for Ligand Discovery and Mechanism | 1 | 2025 |
| R35GM122517 | Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer Biology | 1 | 2025 |
| R35GM130389 | Lessons Learned from PKA: Assembly of Dynamic Macromolecular Switches | 1 | 2025 |
| R35GM136426 | Mechanisms of Post-transcriptional Gene Regulation by RNA Binding Proteins | 1 | 2025 |
| R35GM140837 | Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR | 1 | 2025 |
| R37CA233770 | Combining senescence-inducing and senolytic agents to improve melanoma therapy | 1 | 2025 |
| R50CA211499 | A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer | 1 | 2025 |
| R50CA211506 | Preclinical Models for Cancer Therapeutic Development | 1 | 2025 |
| RM1HG008935 | Center for dynamic RNA epitranscriptomes - Renewal | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/grants?page=10